This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
NAD, PGC-1alpha and SIRT3 as Therapeutics Targets for Huntingtons Disease
Investments > €500k
United States of America
Huntington’s disease
2016